(Q35179415)

7 August 2017

1 reference

title

Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies (English)

1 reference

7 August 2017

1 reference

2

Giorgio V Scagliotti

1 reference

7 August 2017

Marileila Varella-Garcia

series ordinal

4

object named as

Marileila Varella-Garcia

1 reference

7 August 2017

1

Fred R Hirsch

1 reference

7 August 2017

3

Corey J Langer

1 reference

7 August 2017

Wilbur A Franklin

5

1 reference

7 August 2017

publication date

1 August 2003

1 reference

7 August 2017

1 reference

7 August 2017

volume

41 Suppl 1

1 reference

7 August 2017

page(s)

S29-42

1 reference

Global cancer statistics in the year 2000.

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Novel targets for lung cancer therapy: part I.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Tyrosine kinase inhibitors targeted to the epidermal growth factor receptor subfamily: role as anticancer agents

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

EGF receptor as a therapeutic target

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Regulators and Effectors of ras Proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Farnesyltransferase and geranylgeranyltransferase I inhibitors in cancer therapy: important mechanistic and bench to bedside issues

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

The potential of farnesyltransferase inhibitors as cancer chemotherapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Inhibition of ras prenylation: A novel approach to cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Potential roles of antisense technology in cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Antisense oligonucleotides demonstrate a dominant role of c-Ki-RAS proteins in regulating the proliferation of diploid human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Epidermal growth factor induces cyclin D1 in a human prostate cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Transcriptional regulation of the EGF receptor promoter by HPV16 and retinoic acid in human ectocervical epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Retinoic acid and N-(4-hydroxy-phenyl) retinamide suppress growth of esophageal squamous carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Retinoic acid normalizes the increased gene transcription rate of TGF-alpha and EGFR in head and neck cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Phosphatidylinositol-3-OH kinase as a direct target of Ras

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Targeting RAS signalling pathways in cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Cellular survival: a play in three Akts

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Effects of deguelin on the phosphatidylinositol 3-kinase/Akt pathway and apoptosis in premalignant human bronchial epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

AKT and the phosphatidylinositol 3-kinase/AKT pathway: important molecular targets for lung cancer prevention and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

PROGNOSTIC VALUE OF ANGIOGENESIS IN OPERABLE NON-SMALL CELL LUNG CANCER

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

bcl-2 and c-erbB-2 proteins are involved in the regulation of VEGF and of thymidine phosphorylase angiogenic activity in non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

A biological staging model for operable non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

1 reference

7 January 2021

The epidermal growth factor receptor and its inhibition in cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Constitutive Activation of Phosphatidylinositol 3-Kinase by a Naturally Occurring Mutant Epidermal Growth Factor Receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Effect of epidermal growth factor on cadherin-mediated adhesion in a human oesophageal cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Overexpression of ERBB2 in human mammary epithelial cells signals inhibition of transcription of the E-cadherin gene

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

1 reference

7 January 2021

Transcription factors as targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Inhibition of cyclooxygenase-2 expression. An approach to preventing head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Epidermal growth factor receptors and cyclooxygenase-2 in the pathogenesis of non-small cell lung cancer: potential targets for chemoprevention and systemic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

NF-kappa B: a lesson in family values

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Increased expression of epidermal growth factor receptor in rat pleural mesothelial cells correlates with carcinogenicity of mineral fibres

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Epidermal growth factor receptor family in lung cancer and premalignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated non-small-cell lung cancer: an immunohistochemical study on cryosections

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Immunocytochemical markers in stage I lung cancer: relevance to prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Do Molecular Markers Predict Survival in Non–Small-Cell Lung Cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Prognostic significance of HER-2/neu overexpression in stage I adenocarcinoma of lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Overexpression of the c-erbB-2/neu-encoded p185 protein in primary lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

p53, c-erbB-2 and nm23 expression have no prognostic significance in primary pulmonary adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900137-5

7 January 2021

10.1016/S0169-5002(03)00137-5

Identifiers

DOI

1 reference

7 August 2017

1 reference